Simplex Trading, LLC Intercept Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$9.99 - $18.71 $6,423 - $12,030	-643 Reduced 31.72%	1,384 $25,000
Q2 2023 Aug 04, 2023	SELL	$9.17 - $19.29 $297,428 - $625,671	-32,435 Reduced 94.12%	2,027 $22,000
Q1 2023 Apr 27, 2023	BUY	$12.53 - $21.71 $431,808 - $748,170	34,462 New	34,462 $462,000
Q3 2022 Nov 04, 2022	BUY	$12.21 - $19.7 $35,970 - $58,036	2,946 Added 270.28%	4,036 $56,000
Q2 2022 Aug 03, 2022	SELL	$11.23 - $19.59 $166,877 - $291,107	-14,860 Reduced 93.17%	1,090 $15,000
Q1 2022 May 02, 2022	BUY	$13.37 - $17.79 $213,251 - $283,750	15,950 New	15,950 $259,000
Q1 2021 Apr 26, 2021	SELL	$19.33 - $37.75 $28,994 - $56,625	-1,500 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$46.7 - $92.04 $70,050 - $138,060	1,500 New	1,500 $71,000
Q1 2020 Apr 29, 2020	SELL	$48.35 - $118.68 $659,203 - $1.62 Million	-13,634 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$57.36 - $124.1 $629,526 - $1.36 Million	10,975 Added 412.75%	13,634 $1.69 Million
Q3 2019 Oct 15, 2019	BUY	$58.69 - $80.46 $156,056 - $213,943	2,659 New	2,659 $176,000
Q2 2019 Jul 26, 2019	SELL	$77.77 - $120.68 $1.46 Million - $2.26 Million	-18,729 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$91.83 - $120.68 $1.33 Million - $1.75 Million	14,498 Added 342.66%	18,729 $0
Q4 2018 Jan 16, 2019	SELL	$85.79 - $126.46 $623,779 - $919,490	-7,271 Reduced 63.22%	4,231 $426,000
Q3 2018 Oct 23, 2018	BUY	$88.49 - $127.55 $468,908 - $675,887	5,299 Added 85.43%	11,502 $1.45 Million
Q2 2018 Jul 30, 2018	SELL	$60.0 - $85.67 $103,680 - $148,037	-1,728 Reduced 21.79%	6,203 $520,000
Q1 2018 Apr 26, 2018	BUY	$52.72 - $67.25 $214,834 - $274,043	4,075 Added 105.68%	7,931 $487,000
Q4 2017 Jan 10, 2018	BUY	$58.2 - $72.76 $224,419 - $280,562	3,856	3,856 $225,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account